Does Humana Cover ADHD Treatment in Hawaii? A 2026 Guide

Last updated: July 17, 2026

Key facts for Humana Medicare Advantage members in Hawaii: Humana offers Medicare Advantage (MA) plans only in Hawaii — the company exited the commercial market in 2024. All ADHD coverage on Humana Hawaii plans is governed by CMS 42 CFR Part 422 (federal Medicare rules), not Hawaii state commercial insurance law. All stimulant medications require prior authorization (PA) under the Humana Pharmacy Solutions (HPS) formulary — including generic Tier 1-2 stimulants, which is more restrictive than some commercial insurers. Schedule II stimulants (amphetamine salts, methylphenidate, lisdexamfetamine) require electronic prescribing (EPCS) under Hawaii law (HRS § 329-38.5). Non-stimulant ADHD medications are not scheduled controlled substances and are entirely exempt from Hawaii’s EPCS requirement. If you have Humana Medicare Advantage and need ADHD treatment, Klarity Health connects you with licensed, EPCS-compliant providers who understand Medicare Advantage coverage requirements.

Humana and ADHD Coverage in Hawaii: What Medicare Advantage Members Need to Know

Humana is a major Medicare Advantage insurer in Hawaii, offering plan types including Humana Gold Plus HMO, HumanaChoice PPO, and Honor HMO-POS through its Medicare Advantage network. Unlike UnitedHealthcare, HMSA, Aetna, and Cigna — which offer commercial health insurance in Hawaii — Humana exited the commercial market in 2024 and now serves Hawaii exclusively through Medicare Advantage plans.

This distinction matters significantly for ADHD coverage. Commercial plans in Hawaii are regulated by Hawaii state insurance law, including the Hawaii Mental Health Parity Law (Haw. Rev. Stat. § 431M-1) and the Hawaii Prepaid Health Care Act (HRS § 393). Humana Medicare Advantage plans, however, are governed entirely by federal Medicare rules under CMS 42 CFR Part 422 — not state commercial insurance statutes. Federal mental health parity (MHPAEA) applies to Medicare Advantage through CMS regulatory oversight.

For Hawaii seniors and individuals aged 65 and older with Medicare Advantage through Humana, ADHD treatment coverage may be available — but all stimulant medications require prior authorization, and the EPCS requirement under HRS § 329-38.5 applies to Schedule II stimulants regardless of whether you have commercial or MA coverage.

Need help navigating Humana Medicare Advantage ADHD coverage? Verify your Humana benefits at Klarity Health — our licensed providers are experienced with Medicare Advantage requirements and EPCS-compliant prescribing in Hawaii.

Humana Pharmacy Solutions (HPS) ADHD Formulary — Hawaii 2026

Humana Medicare Advantage plans in Hawaii use the Humana Pharmacy Solutions (HPS) formulary for prescription drug benefits (Part D). Unlike commercial insurers that use external PBMs like OptumRx, CVS Caremark, or Express Scripts, Humana manages its Part D formulary in-house through HPS.

Important: Under the HPS Medicare Advantage formulary, all stimulant medications require prior authorization — including generic Tier 1-2 stimulants. This applies to amphetamine salts, methylphenidate, dextroamphetamine, and mixed amphetamine salts at every tier level. This is more restrictive than some commercial plans, where generic Tier 1-2 stimulants may be dispensed without PA.

Note: HPS formulary tiers and PA requirements may vary by specific Humana Medicare Advantage plan type (HMO vs. PPO), plan year, and Hawaii service area. Always verify your specific plan’s drug list at Humana.com or by calling HPS at 1-800-379-0092 before starting treatment.

Prior Authorization for ADHD Medications on Humana Medicare Advantage

Because all stimulant medications require PA under the HPS formulary, understanding the prior authorization process is critical for Humana Medicare Advantage members in Hawaii seeking ADHD treatment.

How PA Works on Humana Medicare Advantage

• Who submits the PA: Your prescribing provider submits the PA request to HPS on your behalf. Klarity Health providers handle this directly.
• PA portal: Providers typically submit through Availity (availity.com) or humana.com/providers. Humana also accepts fax submissions for Medicare Advantage PA requests.
• Standard processing time: 72 hours (3 business days) for standard PA requests; 24 hours for urgent/expedited requests under CMS rules.
• CMS appeal rights: Under CMS 42 CFR Part 422, you have the right to appeal PA denials through Humana’s internal appeals process, and further to an Independent Review Entity (IRE) and Medicare appeals courts if needed.
• Step therapy: For brand stimulants (Adderall XR, Vyvanse, Concerta), HPS typically requires documentation that generic equivalents were tried and were inadequate before approving the brand.

What Your Provider Will Need to Document

• ADHD diagnosis confirmed by a licensed clinician (DSM-5 criteria)
• Functional impairment documented in clinical notes
• Medical necessity for the specific stimulant requested
• For brand medications: prior trial and documented failure or intolerance of generic alternatives
• EPCS-compliant electronic prescription for Schedule II stimulants (required by HRS § 329-38.5)

Hawaii EPCS Law and Humana ADHD Prescriptions

Hawaii’s Electronic Prescribing of Controlled Substances (EPCS) law — Haw. Rev. Stat. § 329-38.5 — applies to Schedule II controlled substances. This requirement applies to all prescribers and all patients in Hawaii, regardless of whether coverage comes through a commercial insurer or a Medicare Advantage plan.

Which ADHD Medications Require EPCS in Hawaii

Under HRS § 329-38.5, electronic prescribing is required for Schedule II controlled substances. All stimulant ADHD medications fall under Schedule II:

• Amphetamine salts (Adderall, Adderall XR, generic equivalents) — Schedule II → EPCS required
• Methylphenidate (Ritalin, Concerta, generic equivalents) — Schedule II → EPCS required
• Dextroamphetamine (Dexedrine, ProCentra) — Schedule II → EPCS required
• Lisdexamfetamine (Vyvanse, generic if available) — Schedule II → EPCS required
• Methamphetamine (Desoxyn — rarely used for ADHD) — Schedule II → EPCS required

Which ADHD Medications Do NOT Require EPCS in Hawaii

Non-stimulant ADHD medications are not scheduled controlled substances. HRS § 329-38.5 applies only to Schedule II — non-stimulants fall entirely outside the EPCS requirement:

• Atomoxetine (Strattera, generic) — non-scheduled → EPCS entirely inapplicable
• Guanfacine ER (Intuniv, generic) — non-scheduled → EPCS entirely inapplicable
• Clonidine ER (Kapvay, generic) — non-scheduled → EPCS entirely inapplicable
• Viloxazine (Qelbree) — non-scheduled → EPCS entirely inapplicable

Important distinction from West Virginia: West Virginia’s EPCS law (W. Va. Code § 60A-4-403a) covers all controlled substances — including Schedule III, IV, and V. Hawaii’s HRS § 329-38.5 covers Schedule II only. This means that medications like Schedule IV phentermine (weight loss) or Schedule IV benzodiazepines (anxiety) trigger EPCS in WV but do NOT trigger EPCS in Hawaii. For ADHD specifically, however, the primary medications are Schedule II — so EPCS applies fully in Hawaii for stimulant prescriptions.

All Klarity Health providers are EPCS-compliant and fully equipped to prescribe Schedule II stimulants electronically under HRS § 329-38.5.

Federal Mental Health Parity on Humana Medicare Advantage

Humana Medicare Advantage plans must comply with the Mental Health Parity and Addiction Equity Act (MHPAEA) as implemented through CMS 42 CFR Part 422. This federal framework requires that mental health and substance use disorder benefits — including ADHD treatment — be offered on terms no more restrictive than medical/surgical benefits of the same classification.

What This Means for Humana MA Members

• PA requirements for ADHD stimulants must not be more burdensome than PA requirements for comparable medical conditions
• Quantity limits on stimulants must be comparable to limits on non-psychiatric medications of similar clinical complexity
• Coverage exclusions for ADHD treatment are generally prohibited if comparable medical conditions are covered
• If you believe Humana has applied more restrictive standards to your ADHD coverage than to comparable medical benefits, you may file a parity complaint with CMS at 1-800-633-4227

How This Differs from Commercial Plans

Commercial insurers in Hawaii (UnitedHealthcare, HMSA, Aetna, Cigna) are subject to Hawaii state parity law under Haw. Rev. Stat. § 431M-1, which is enforced by the Hawaii Insurance Division (1-808-586-2790). Humana Medicare Advantage plans are not subject to Haw. Rev. Stat. § 431M-1 — federal CMS oversight applies instead. Parity complaints for Humana MA should be directed to CMS, not the Hawaii Insurance Division.

Similarly, the Hawaii Prepaid Health Care Act (HRS § 393) — which requires employers with employees working 20 or more hours per week to provide health insurance — applies to commercial employer health plans, not Medicare Advantage. If you are enrolled in Humana MA, HRS § 393 does not govern your coverage.

Medicaid and Dual-Eligible Members

Some Humana Medicare Advantage members in Hawaii may also be enrolled in Hawaii Medicaid (Med-QUEST), making them dual-eligible (Medicare + Medicaid). If you are dual-eligible:

• Humana may offer Dual Eligible Special Needs Plans (D-SNPs) coordinating Medicare and Medicaid benefits
• ADHD medication coverage may be available through both Medicare Part D (HPS formulary) and Hawaii Medicaid, with coordination of benefits applying
• PA requirements and formulary tiers may differ for dual-eligible members — verify your specific D-SNP plan details with Humana at 1-800-448-6262
• Hawaii Med-QUEST covers ADHD treatment including stimulant medications for eligible adults — contact the Hawaii Department of Human Services Med-QUEST Division at 1-800-316-8005 for Medicaid-specific coverage questions

Disclaimer: This content describes Medicare Advantage plan coverage only. Medicaid coverage terms, eligibility, and benefits are governed separately by Hawaii Med-QUEST and may differ significantly from Medicare Advantage coverage. Individuals who may qualify for Medicaid should contact the Hawaii Department of Human Services for Medicaid-specific guidance.

What ADHD Services May Be Covered by Humana Medicare Advantage

Beyond prescription coverage, Humana Medicare Advantage plans in Hawaii may cover a range of ADHD-related services. Coverage terms vary by specific plan and require verification:

• ADHD evaluation and diagnosis — psychiatric evaluation, neuropsychological testing (coverage varies by plan)
• Outpatient psychiatric visits — including telehealth consultations with licensed providers
• Medication management — follow-up visits for prescription adjustments
• Individual therapy — cognitive behavioral therapy (CBT) for ADHD, behavioral skills training
• Telehealth ADHD treatment — Medicare telehealth coverage expanded significantly after 2020 and continues under current CMS rules for MA plans
• Stimulant prescriptions — subject to HPS formulary PA requirements as described above
• Non-stimulant prescriptions — generally lower PA burden, no EPCS requirement

5-Step Guide to Verifying Your Humana Medicare Advantage ADHD Coverage

1. Locate your Evidence of Coverage (EOC): Log in to Humana.com or MyHumana app to access your specific plan’s Evidence of Coverage document for 2026. This is the authoritative source for your plan’s ADHD coverage terms.
2. Check your plan’s drug list (formulary): Visit Humana.com → Plans & Benefits → Prescription Drug Coverage → Drug Formulary. Search for your specific ADHD medication to confirm tier, PA requirement, and quantity limits.
3. Call HPS to confirm PA requirements: Reach Humana Pharmacy Solutions at 1-800-379-0092. Ask specifically: (a) does my plan require PA for [medication name]? (b) What documentation does my prescriber need to submit? (c) What is the standard processing time?
4. Confirm EPCS compliance for stimulants: If you are prescribed a Schedule II stimulant (amphetamine salts, methylphenidate, lisdexamfetamine, dextroamphetamine), confirm that your prescriber uses EPCS-certified software compliant with HRS § 329-38.5. Klarity Health providers are fully EPCS-compliant.
5. Verify telehealth ADHD coverage: Call Humana Member Services at 1-800-448-6262 to confirm whether ADHD telehealth visits through providers like Klarity Health are covered under your specific Medicare Advantage plan in Hawaii.

Klarity Health: EPCS-Compliant ADHD Treatment for Humana Medicare Advantage Members

Klarity Health’s network of 2,000+ licensed providers includes clinicians experienced with Medicare Advantage ADHD coverage requirements and EPCS-compliant prescribing under Hawaii law. Whether you need stimulant or non-stimulant ADHD treatment, our providers can support the PA process and ensure your prescriptions meet HRS § 329-38.5 requirements.

See if your Humana Medicare Advantage plan may cover ADHD treatment at Klarity Health.

Contact Information

• Humana Member Services: 1-800-448-6262 | Humana.com | MyHumana app
• Humana Pharmacy Solutions (HPS): 1-800-379-0092
• Humana Provider PA Portal: Availity (availity.com) | humana.com/providers
• Hawaii Insurance Division: 1-808-586-2790 | insurance.hawaii.gov (for commercial plan complaints; Humana MA complaints go to CMS)
• CMS Medicare Helpline: 1-800-633-4227 | Medicare.gov (for MA plan parity complaints and appeals)
• Hawaii Med-QUEST (Medicaid): 1-800-316-8005
• Hawaii DLIR: 1-808-586-8777 (for Hawaii Prepaid Health Care Act questions — commercial plans only)
• SAMHSA National Helpline: 1-800-662-4357

Frequently Asked Questions

Does Humana cover Adderall for adults on Medicare Advantage in Hawaii?

Adderall and its generic equivalents (amphetamine salts) may be covered under Humana Medicare Advantage plans in Hawaii through the HPS formulary. However, all stimulant medications — including generics at Tier 1-2 — require prior authorization under HPS. Your prescriber will need to submit a PA request before your pharmacy can fill the prescription. Adderall is also a Schedule II controlled substance, so your provider must use EPCS-compliant software under HRS § 329-38.5. Contact HPS at 1-800-379-0092 to verify coverage for your specific plan.

Do I need a referral for ADHD treatment with Humana Medicare Advantage in Hawaii?

Referral requirements depend on your specific plan type. Humana Gold Plus HMO plans typically require a referral from your primary care provider to see a psychiatrist or specialist. HumanaChoice PPO plans generally allow you to see specialists without a referral. Review your Evidence of Coverage or call 1-800-448-6262 to confirm referral requirements for your specific plan.

Is Vyvanse covered by Humana Medicare Advantage in Hawaii?

Vyvanse (lisdexamfetamine) may be covered under Humana MA plans in Hawaii at Tier 3-4 with PA and step therapy requirements. HPS will typically require documentation that generic stimulant alternatives were tried and were inadequate before approving brand Vyvanse. A generic lisdexamfetamine may be available — verify with HPS at 1-800-379-0092 whether it is on your specific plan’s formulary. Vyvanse is a Schedule II controlled substance and requires EPCS-compliant prescribing in Hawaii.

Why doesn’t Hawaii state parity law apply to my Humana Medicare Advantage plan?

Humana Medicare Advantage plans are federal Medicare plans governed by CMS 42 CFR Part 422. Hawaii state insurance law — including the Mental Health Parity Law (Haw. Rev. Stat. § 431M-1) and the Prepaid Health Care Act (HRS § 393) — applies only to commercial health insurance plans regulated by the state. Federal MHPAEA parity protections do apply to Medicare Advantage through CMS oversight, so you still have parity rights — they are enforced at the federal level through CMS (1-800-633-4227) rather than through the Hawaii Insurance Division.

Do non-stimulant ADHD medications require EPCS in Hawaii?

No. Hawaii’s EPCS law (HRS § 329-38.5) applies only to Schedule II controlled substances. Non-stimulant ADHD medications — including atomoxetine (Strattera), guanfacine ER (Intuniv), clonidine ER (Kapvay), and viloxazine (Qelbree) — are not scheduled controlled substances. EPCS is entirely inapplicable to these medications in Hawaii. They may still require prior authorization under the HPS formulary, but the EPCS prescribing requirement does not apply.

Can I appeal a PA denial for ADHD stimulants from Humana?

Yes. If Humana denies a PA request for an ADHD stimulant, you have appeal rights under CMS 42 CFR Part 422. Steps include: (1) Request a formal reconsideration from Humana within 60 days of the denial; (2) If Humana upholds the denial, the case is automatically forwarded to an Independent Review Entity (IRE); (3) Further appeals may go to an Administrative Law Judge (ALJ), the Medicare Appeals Council, and federal district court. Your provider can submit clinical documentation supporting medical necessity. Call Humana Member Services at 1-800-448-6262 to initiate an appeal.

Disclaimer: Coverage details in this guide are based on generally available information about Humana Medicare Advantage plans and the HPS formulary. Actual coverage for ADHD medications varies by specific plan, formulary year, Hawaii service area, and individual member circumstances. This content uses language such as “may,” “typically,” “often,” and “in many cases” intentionally — coverage is not guaranteed. Always verify your benefits directly with Humana before scheduling treatment. Klarity Health is not affiliated with Humana, CMS, or any insurer, and cannot guarantee coverage outcomes.